The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling
Open accessAbstract
Sphingosine kinase (SK) 1 catalyzes the formation of the bioactive lipid sphingosine 1-phosphate, and has been implicated in several biological processes in mammalian cells, including enhanced proliferation, inhibition of apoptosis, and oncogenesis. Human SK (hSK) 1 possesses high instrinsic catalytic activity which can be further increased by a diverse array of cellular agonists. We have shown previously that this activation occurs as a direct consequence of extracellular signal–regulated kinase 1/2–mediated phosphorylation at Ser225, which not only increases catalytic activity, but is also necessary for agonist-induced translocation of hSK1 to the plasma membrane. In this study, we report that the oncogenic effects of overexpressed hSK1 are blocked by mutation of the phosphorylation site despite the phosphorylation-deficient form of the enzyme retaining full instrinsic catalytic activity. This indicates that oncogenic signaling by hSK1 relies on a phosphorylation-dependent function beyond increasing enzyme activity. We demonstrate, through constitutive localization of the phosphorylation-deficient form of hSK1 to the plasma membrane, that hSK1 translocation is the key effect of phosphorylation in oncogenic signaling by this enzyme. Thus, phosphorylation of hSK1 is essential for oncogenic signaling, and is brought about through phosphorylation-induced translocation of hSK1 to the plasma membrane, rather than from enhanced catalytic activity of this enzyme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Melendez, A. J., & Khaw, A. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110944200 · Cited by 159
RetractedSphingosine 1-phosphate signalling in mammalian cells
Pyne, S., & Pyne, N. J. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3490385 · Cited by 735
Liu, H., Sugiura, M., Nava, V. E., Edsall, L. C., Kono, K., Poulton, S., Milstien, S., Kohama, T., & Spiegel, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002759200 · Cited by 667
Discovery and evaluation of inhibitors of human sphingosine kinase.
French, K. J., Schrecengost, R. S., Lee, B. D., Zhuang, Y., Smith, S. N., Eberly, J. L., Yun, J. K., & Smith, C. D. (2003) · PubMed · Cited by 599
Sphingosine 1-Phosphate, a Key Cell Signaling Molecule
Spiegel, S., & Milstien, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200007200 · Cited by 555
Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation
Pitson, S. M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg540 · Cited by 542
Self-citationOlivera, A., Kohama, T., Edsall, L., Nava, V., Cuvillier, O., Poulton, S., & Spiegel, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.3.545 · Cited by 518
An oncogenic role of sphingosine kinase
Xia, P., Gamble, J. R., Wang, L., Pitson, S. M., Moretti, P. A. B., Wattenberg, B. W., D'Andrea, R. J., & Vadas, M. A. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00834-4 · Cited by 394
Self-citationSphingosine Kinase Type 2 Is a Putative BH3-only Protein That Induces Apoptosis
Liu, H., Toman, R. E., Goparaju, S. K., Maceyka, M., Nava, V. E., Sankala, H., Payne, S. G., Bektas, M., Ishii, I., Chun, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304455200 · Cited by 356
Sphingosine Kinase Interacts with TRAF2 and Dissects Tumor Necrosis Factor-α Signaling
Xia, P., Wang, L., Moretti, P. A. B., Albanese, N., Chai, F., Pitson, S. M., D'Andrea, R. J., Gamble, J. R., & Vadas, M. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111423200 · Cited by 296
Self-citation
Cited by
G-protein-coupled receptors and cancer
Dorsam, R. T., & Gutkind, J. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2069 · Cited by 1,388
Wymann, M. P., & Schneiter, R. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2335 · Cited by 1,291
An Overview of Sphingolipid Metabolism: From Synthesis to Breakdown
Gault, C. R., Obeid, L. M., & Hannun, Y. A. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-6741-1_1 · Cited by 1,071
Sphingosine 1-phosphate and cancer
Pyne, N. J., & Pyne, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2875 · Cited by 852
“Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic Targets
Takabe, K., Paugh, S. W., Milstien, S., & Spiegel, S. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07113 · Cited by 718
Metadata
- Authors
- Pitson, S. M., Xia, P., Leclercq, T. M., Moretti, P. A. B., Zebol, J. R., Lynn, H. E., Wattenberg, B. W., & Vadas, M. A.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2004-12-28
- Volume
- 201
- Issue
- 1
- Pages
- 49-54
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2151948261
- Cited by
- 268
- References
- 21
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling. https://app.cochat.ai/papers/10.1084/jem.20040559
- The paper
- Pitson, S. M., Xia, P., Leclercq, T. M., Moretti, P. A. B., Zebol, J. R., Lynn, H. E., Wattenberg, B. W., & Vadas, M. A. (2005). Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling. The Journal of Experimental Medicine. https://doi.org/10.1084/jem.20040559
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.